Trial Profile
A Randomized, Double blind, Active controlled, Phase 2 Clinical Trial to Assess the Immunogenicity and Safety of GBP411 in Healthy Infants
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Jun 2017
Price :
$35
*
At a glance
- Drugs GBP 411 (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Sponsors SK Chemicals
- 06 Jun 2017 New trial record